Tirzepatide emerges a groundbreaking treatment agent for individuals struggling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://theresacfin999424.loginblogin.com/48679086/tirzepatide-a-new-frontier-in-diabetes-treatment